Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo.
Sepsis is characterized by the development of adaptive immune cell alterations, which intensity and duration are associated with increased risk of health-care associated infections and mortality. However, pathophysiological mechanisms leading to such lymphocyte dysfunctions are not completely unders...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4671586?pdf=render |
| _version_ | 1818132693355855872 |
|---|---|
| author | Fanny Poujol Guillaume Monneret Alexandre Pachot Julien Textoris Fabienne Venet |
| author_facet | Fanny Poujol Guillaume Monneret Alexandre Pachot Julien Textoris Fabienne Venet |
| author_sort | Fanny Poujol |
| collection | DOAJ |
| description | Sepsis is characterized by the development of adaptive immune cell alterations, which intensity and duration are associated with increased risk of health-care associated infections and mortality. However, pathophysiological mechanisms leading to such lymphocyte dysfunctions are not completely understood, although both intrinsic lymphocyte alterations and antigen-presenting cells (APCs) dysfunctions are most likely involved.The aim of the current study was to evaluate whether lipopolysaccharide (LPS, mimicking initial Gram negative bacterial challenge) could directly impact lymphocyte function after sepsis. Therefore, we explored ex-vivo the effect of LPS priming on human T lymphocyte proliferation induced by different stimuli.We showed that LPS priming of PBMCs reduced T cell proliferative response and altered IFNγ secretion after stimulation with OKT3 but not with phytohaemagglutinin or anti-CD2/CD3/CD28-coated beads stimulations. Interestingly only LPS priming of monocytes led to decreased T cell proliferative response as opposed to LPS priming of lymphocytes. Importantly, LPS priming was associated with reduced expression of HLA-DR, CD86 and CD64 on monocytes but not with the modification of CD3, CTLA4, PD-1 and CD28 expressions on lymphocytes. Finally, IFNγ stimulation restored monocytes accessory functions and T cell proliferative response to OKT3.We conclude that LPS priming does not directly impact lymphocyte functions but reduces APC's capacity to activate T cells. This recapitulates ex vivo indirect mechanisms participating in sepsis-induced lymphocyte alterations and suggests that monocyte-targeting immunoadjuvant therapies in sepsis may also help to improve adaptive immune dysfunctions. Direct mechanisms impacting lymphocytes being also at play during sepsis, the respective parts of direct versus indirect sepsis-induced lymphocyte alterations remain to be evaluated in clinic. |
| first_indexed | 2024-12-11T08:40:53Z |
| format | Article |
| id | doaj.art-af2288e962584aafa79a5a478e9445fa |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T08:40:53Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-af2288e962584aafa79a5a478e9445fa2022-12-22T01:14:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014437510.1371/journal.pone.0144375Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo.Fanny PoujolGuillaume MonneretAlexandre PachotJulien TextorisFabienne VenetSepsis is characterized by the development of adaptive immune cell alterations, which intensity and duration are associated with increased risk of health-care associated infections and mortality. However, pathophysiological mechanisms leading to such lymphocyte dysfunctions are not completely understood, although both intrinsic lymphocyte alterations and antigen-presenting cells (APCs) dysfunctions are most likely involved.The aim of the current study was to evaluate whether lipopolysaccharide (LPS, mimicking initial Gram negative bacterial challenge) could directly impact lymphocyte function after sepsis. Therefore, we explored ex-vivo the effect of LPS priming on human T lymphocyte proliferation induced by different stimuli.We showed that LPS priming of PBMCs reduced T cell proliferative response and altered IFNγ secretion after stimulation with OKT3 but not with phytohaemagglutinin or anti-CD2/CD3/CD28-coated beads stimulations. Interestingly only LPS priming of monocytes led to decreased T cell proliferative response as opposed to LPS priming of lymphocytes. Importantly, LPS priming was associated with reduced expression of HLA-DR, CD86 and CD64 on monocytes but not with the modification of CD3, CTLA4, PD-1 and CD28 expressions on lymphocytes. Finally, IFNγ stimulation restored monocytes accessory functions and T cell proliferative response to OKT3.We conclude that LPS priming does not directly impact lymphocyte functions but reduces APC's capacity to activate T cells. This recapitulates ex vivo indirect mechanisms participating in sepsis-induced lymphocyte alterations and suggests that monocyte-targeting immunoadjuvant therapies in sepsis may also help to improve adaptive immune dysfunctions. Direct mechanisms impacting lymphocytes being also at play during sepsis, the respective parts of direct versus indirect sepsis-induced lymphocyte alterations remain to be evaluated in clinic.http://europepmc.org/articles/PMC4671586?pdf=render |
| spellingShingle | Fanny Poujol Guillaume Monneret Alexandre Pachot Julien Textoris Fabienne Venet Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo. PLoS ONE |
| title | Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo. |
| title_full | Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo. |
| title_fullStr | Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo. |
| title_full_unstemmed | Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo. |
| title_short | Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo. |
| title_sort | altered t lymphocyte proliferation upon lipopolysaccharide challenge ex vivo |
| url | http://europepmc.org/articles/PMC4671586?pdf=render |
| work_keys_str_mv | AT fannypoujol alteredtlymphocyteproliferationuponlipopolysaccharidechallengeexvivo AT guillaumemonneret alteredtlymphocyteproliferationuponlipopolysaccharidechallengeexvivo AT alexandrepachot alteredtlymphocyteproliferationuponlipopolysaccharidechallengeexvivo AT julientextoris alteredtlymphocyteproliferationuponlipopolysaccharidechallengeexvivo AT fabiennevenet alteredtlymphocyteproliferationuponlipopolysaccharidechallengeexvivo |